Latest News

Cannabis constituent has no effect on multiple sclerosis progression, study shows

The first large non-commercial clinical study to investigate whether the main active constituent of cannabis (tetrahydrocannabinol or THC) is effective in slowing the course of progressive multiple sclerosis, shows that there is no evidence to suggest this; although benefits were noted for those at the lower end of the disability scale.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Why should adolescents exhibiting symptoms of mental disorders be asked about hallucinations?

  • How are student loans affecting the well-being of young adults?

  • Rare neurological disease shines light on health of essential nerve cells

  • Ecocentricity: How Do Consumers Decide What Makes a Product 'Green'?

  • Does corporate social responsibility reduce negative reviews for bad service?

  • Health Consciousness: Do Consumers Believe Healthy Food Always Tastes Bad?

  • Heightened scents: Do ambient fragrances make consumers purchase more?

  • Five strategies scholars use in writing medical review articles

  • Sleeping on stomach may increase risk of sudden death in epilepsy

  • Alternative DNA repair mechanism could provide better treatment for neuroblastoma in kids

  •